These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1820929)

  • 1. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
    Pereira LM; Maya MT; Morais JA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
    Dansirikul C; Choi M; Duffull SB
    Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics.
    Marsh RE; Riauka TA; McQuarrie SA
    J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reanalysis of carbamazepine and carbamazepine-epoxide pharmacokinetics after multiple dosing of extended release formulation.
    Konsil J; Dechasathian S; Mason DH; Stevens RE
    J Pharm Pharm Sci; 2002; 5(2):169-75. PubMed ID: 12207869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
    Russell RW; Drane JW
    J Dairy Sci; 1992 Dec; 75(12):3455-64. PubMed ID: 1474212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study.
    Terziivanov D; Atanasova I; Dimitrova V
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization algorithms and weighting factors for analysis of dynamic PET studies.
    Yaqub M; Boellaard R; Kropholler MA; Lammertsma AA
    Phys Med Biol; 2006 Sep; 51(17):4217-32. PubMed ID: 16912378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of direct search optimization for pharmacokinetic parameter estimation.
    Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
    J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of procedures for determining Michaelis-Menten parameters together with their standard deviations using simulated measurement series].
    Hoppe H; Cumme GA
    Acta Biol Med Ger; 1978; 37(8):1177-84. PubMed ID: 749454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TopFit: a PC-based pharmacokinetic/pharmacodynamic data analysis program.
    Tanswell P; Koup J
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):514-20. PubMed ID: 8262691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
    Wyska E; Szymura-Oleksiak J; Pekala E; Obruśnik A
    J Pharm Pharmacol; 2007 Apr; 59(4):495-501. PubMed ID: 17430632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Windows based general PBPK/PD modeling software.
    Luecke RH; Pearce BA; Wosilait WD; Doerge DR; Slikker W; Young JF
    Comput Biol Med; 2008 Sep; 38(9):962-78. PubMed ID: 18657803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MS-DOS and Macintosh pharmacokinetic analysis programs using a two-compartment, two-infusion dosing scheme.
    Hampton EM; Hrdlicka K; Bourne DW
    Clin Pharm; 1991 Mar; 10(3):206-9. PubMed ID: 2040127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of enzyme kinetic parameters based on statistical learning.
    Borger S; Liebermeister W; Klipp E
    Genome Inform; 2006; 17(1):80-7. PubMed ID: 17503358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation for population analysis of Michaelis-Menten elimination kinetics.
    Hashimoto Y; Koue T; Otsuki Y; Yasuhara M; Hori R; Inui K
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):205-16. PubMed ID: 8719237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear least-squares regression analysis by a simplex method using differential equations containing Michaelis-Menten type rate constants.
    Murata K; Kohno K
    Biopharm Drug Dispos; 1989; 10(1):25-34. PubMed ID: 2923959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.